Optimization of a novel kinase inhibitor scaffold for the dual inhibition of JAK2 and FAK kinases.
The elaboration of a novel scaffold for the inhibition of JAK2 and FAK kinases was targeted in order to provide a dual inhibitor that could target divergent pathways for tumor cell progression.